Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
YKYRYL peptide Potential treatment - theoretical effect Experimental Antiviral Aug/27/2020 1 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/15/2020 0 1
Thymosin α1 Potential treatment - clinical evidence Experimental Antiviral Oct/31/2020 1 1
Soybean Trypsin Inhibitor Potential treatment - pre-clinical evidence Natural product Antiviral Apr/12/2021 1 0
SATPdb18674 Potential treatment - theoretical effect Experimental Antiviral Oct/21/2020 1 0
[SARSHRC-PEG4]2-chol Potential treatment - pre-clinical evidence Experimental Antiviral Feb/17/2021 1 0
SARS-CoV-2 HRC lipopeptide Potential treatment - pre-clinical evidence Experimental Antiviral Oct/20/2020 1 0
Sar9, Met (O2)11-Substance P Potential treatment - theoretical effect Experimental Antiviral Jan/08/2021 1 0
REGN-COV2 Emergency use authorization Experimental Antiviral Mar/20/2021 1 0
Peptide #2 Potential treatment - pre-clinical evidence Experimental Antiviral Jan/11/2021 1 0